therivabio.com - TOVX Income before deduction of interest, taxes and amortization

Graphic logo of Theriva Biologics Inc (TOVX)

Theriva Biologics, Inc. (TOVX) is reducing capital expenditures by outsourcing production to cGMP facilities. Cash operating profit illustrates the financial dynamics, where 0.00 serves as the base parameter value. The brand's scientific authority is based on the creation of innovative immunomodulators. High barriers to entry and patent protection reliably shield this oncology segment from new players.

Profit before payment of interest, taxes and amortization: Theriva Biologics, Inc. (TOVX) for 11/23/2025 - 11/17/2026

Theriva Biologics Inc - analytical breakdowns and key metrics (TOVX)

- market value and analyst target forecast:
Analysis of all company metrics:therivabio.com - TOVX
Mass-produced product of Theriva Biologics

This indicator calculates net cash flow from operating activities before depreciation, reflecting the business's actual ability to generate liquidity excluding accounting write-offs. For Theriva Biologics, Inc. (TOVX), the EBITDA timeline reveals the impact of geopolitical barriers and supply chain disruptions on clinical trial costs, allowing a distinction between a temporary drawdown and a systemic efficiency crisis in immunotherapy development.

Competitors of Theriva Biologics, Inc. (TOVX)

ImmunityBio (IBRX) - Profit before interest, taxes and amortization|IMCR: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization JANX (Janux Therapeutics, Inc.)|RCUS: Operating profit EBITDA|ZYME - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization tangotx.com|Operating profit before deduction of amortization iovance.com (IOVA)|Profit before payment of interest, taxes and amortization Immatics NV (IMTX)|Operating profit before deduction of amortization Xencor Corp XNCR|Compass Therapeutics Inc - Operating profit before deduction of amortization|Operating profit EBITDA Replimune Inc. REPL|LYEL - Profit before payment of interest, taxes and amortization|IPHA (innate-pharma.com) - Operating profit before amortization|pyxisoncology.com (PYXS) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Compugen Ltd. (CGEN)|Operating profit before deduction of amortization IOBT|STRO - Operating profit before depreciation charges|Operating profit before deduction of amortization INKT (MiNK)|Company profit before taxes, interest and amortization HOWL|Operating profit EBITDA IMMX (Immix Biopharma, Inc.)|Income before deduction of interest, taxes and amortization ALXO|CUE - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization PDS Biotechnology Corporation|Sonnet BioTherapeutics Holdings Inc. (SONN) - Profit before payment of interest, taxes and amortization|MAIA Biotechnology - Income before deduction of interest, taxes and amortization|LIMN (liminatuspharma.com) - Operating profit EBITDA|Operating profit EBITDA lavatherapeutics.com|Profit before payment of interest, taxes and amortization NextCure (NXTC)|LPTX: Profit before deduction of interest, taxes, depreciation and amortization|Intensity Therapeutics, Inc. - Operating profit before deduction of amortization|Sensei Biotherapeutics (SNSE) - Profit before interest, taxes and amortization|gritstonebio.com - Operating profit EBITDA|KA (Kineta) - Operating profit before amortization|NEXI: Operating profit EBITDA|Turnstone Biologics Corporation (TSBX) - Operating profit EBITDA|VCNX (vaccinex.com) - Operating profit EBITDA|HARP: Income before deduction of interest, taxes and amortization